HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new Executive Vice President and Chief Financial Officer, effective April 15, 2024. Mr. Lakkaraju joins Bio-Rad from Benchmark Electronics, a multi-national leader […]
GLENDALE HEIGHTS, Ill. — Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC (“Biologos”), a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The partnership with Ampersand will include investments to expand Biologos’ […]
Nuclera recognized as one of UK’s most exciting growth stage companies Official launch of 2024 cohort taken place at 10 Downing Street Cambridge, UK: Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its eProtein Discovery benchtop protein platform, today announced it has been selected to join the Tech Nation Future Fifty 2024 […]
As of the 1st of April 2024, MyBio Ltd. will be the main point of contact for sales and supply of QIAGEN’s world leading “Sample to Insight” solutions for life science customers throughout the island of Ireland. MyBio‘s Founder & CEO, Linda Nolan is delighted to announce this new exclusive partnership with QIAGEN to distribute their Life Science research product portfolio throughout […]
The South African Medical Research Council (SAMRC) and Thermo Fisher Scientific Inc. have signed a Memorandum of Agreement (MOA) to collaborate on the establishment of a Centre of Excellence and training programme in the field of molecular biology and life sciences in South Africa. The purpose of this collaboration is to address the challenges faced […]
Abcam today announced the appointment of Markus Lusser as President. A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio. His extensive commercial and digital experience across the life sciences and medical device industries will help build on Abcam’s momentum to deliver innovative solutions […]
New Location Positions CIL for Product Development and Future Growth Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), has announced it will be relocating and expanding its corporate headquarters to newly purchased space in Tewksbury, MA, to advance the operations and growth of the company. […]
Executive brings more than 25 years of experience in life sciences SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau’s appointment as its new president, succeeding interim president, Greg Milosevich. “Mary brings more than 25 […]
Key appointment to lead global commercial launch of eProtein Discovery platform Cambridge, UK: Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, today announced the appointment of Joseph Bertelsen as Chief Commercial Officer (CCO). With over 20 years’ commercial leadership experience in the life science tools and drug development […]
Following discussions with the board, the company’s founders Erik Gatenholm and Hector Martinez are leaving BICO after eight years. “I want to thank Erik and Hector for their efforts. Without them, the company would not have existed, let alone contributed to the change in the industry,” says Rolf Classon, Chairman of the Board. “I wish […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
